Free Trial

Craneware (CRW) Competitors

Craneware logo
GBX 1,820 +20.00 (+1.11%)
As of 12:17 PM Eastern

CRW vs. EMIS, INS, KOO, RENX, COG, INHC, FDBK, TRLS, IQAI, and DVRG

Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.

Craneware vs.

EMIS Group (LON:EMIS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

EMIS Group has a beta of -0.13, suggesting that its stock price is 113% less volatile than the S&P 500. Comparatively, Craneware has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500.

EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 6.18%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.

Company Net Margins Return on Equity Return on Assets
EMIS Group17.23% 23.17% 7.99%
Craneware 6.18%3.58%2.28%

EMIS Group received 10 more outperform votes than Craneware when rated by MarketBeat users. Likewise, 75.38% of users gave EMIS Group an outperform vote while only 71.94% of users gave Craneware an outperform vote.

CompanyUnderperformOutperform
EMIS GroupOutperform Votes
251
75.38%
Underperform Votes
82
24.62%
CranewareOutperform Votes
241
71.94%
Underperform Votes
94
28.06%

EMIS Group has higher earnings, but lower revenue than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EMIS Group£176.86M0.00£30.48M£0.47N/A
Craneware£230.77M3.40£14.27M£27.0767.43

In the previous week, Craneware had 4 more articles in the media than EMIS Group. MarketBeat recorded 4 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 1.48 beat EMIS Group's score of 0.21 indicating that Craneware is being referred to more favorably in the news media.

Company Overall Sentiment
EMIS Group Neutral
Craneware Positive

Craneware has a consensus price target of GBX 2,800, indicating a potential upside of 53.42%. Given Craneware's stronger consensus rating and higher probable upside, analysts clearly believe Craneware is more favorable than EMIS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EMIS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Craneware
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays an annual dividend of GBX 29 per share and has a dividend yield of 1.6%. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware pays out 107.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio.

105.6% of EMIS Group shares are owned by institutional investors. Comparatively, 60.2% of Craneware shares are owned by institutional investors. 3.6% of EMIS Group shares are owned by insiders. Comparatively, 19.3% of Craneware shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Craneware beats EMIS Group on 11 of the 19 factors compared between the two stocks.

Get Craneware News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRW vs. The Competition

MetricCranewareHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£784.14M£205.38M£5.56B£2.57B
Dividend Yield1.44%6.68%5.11%4.84%
P/E Ratio67.43219.9022.48133.67
Price / Sales3.40472.87395.10244,979.30
Price / Cash14.7247.1438.1828.16
Price / Book1.965.226.774.56
Net Income£14.27M-£15.55M£3.22B£5.85B
7 Day Performance15.14%1.30%1.50%2.98%
1 Month Performance2.53%0.93%4.01%9.28%
1 Year Performance-18.53%9.20%16.16%115.29%

Craneware Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRW
Craneware
3.153 of 5 stars
GBX 1,820
+1.1%
GBX 2,800
+53.8%
-15.5%£781.99M£230.77M67.24734Insider Trade
News Coverage
High Trading Volume
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 145
-2.7%
GBX 456.67
+214.9%
-49.6%£53.22M£50.72M13.62478
RENX
Renalytix
N/AGBX 8
flat
N/A-60.5%£33.16M£9.22M-0.38102Gap Up
COG
Cambridge Cognition
N/AGBX 34
-5.6%
N/A-30.7%£14.23M£15.64M-9.0480Earnings Report
Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.40
-1.1%
N/A-26.8%£8.68M£12.57M-1.7074Positive News
FDBK
Feedback
N/AGBX 13.78
+0.2%
N/A-84.7%£6.04M£3.88M-0.5624Gap Up
TRLS
Trellus Health
N/AGBX 1.62
-1.8%
N/A+11.1%£3.13M£65,831.01-0.4731Gap Up
IQAI
IQ-AI
N/AGBX 0.83
-1.7%
N/A-40.9%£1.84M£538,190.00-13.676Earnings Report
News Coverage
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073

Related Companies and Tools


This page (LON:CRW) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners